Characteristics of HIV-infected children seen in western Kenya

East African Medical Journal

Volumn 86, Issue 8, 2009, Pages 364-373

  Nyandiko, W M ^a,b   Mwangi, A ^b   Ayaya, S O ^a,b   Nabakwe, E C ^a,b   Tenge, C N ^a,b   Gisore, P M ^a,b   Vreeman, R C ^c  

^a MOI UNIVERSITY   (Kenya)

^b ACADEMIC MODEL PROVIDING ACCESS TO HEALTHCARE AMPATH   (Kenya)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; AGE DISTRIBUTION; AIDS RELATED COMPLEX; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; KENYA; MALE; MORPHOMETRICS; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; TUBERCULOSIS; VIROLOGY;

ADOLESCENT; AGE DISTRIBUTION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; BODY WEIGHTS AND MEASURES; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; KENYA; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 77952369159     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. UNAIDS. Report on the global HIV/AIDS epidemic: Global report. Geneva: World Health Organization, 2007.
2. Kenya AIDS indicator survey 2007. Preliminary report. Nairobi, Kenya.
3. World Health Organization. Mortality country fact sheet 2006. http://www. who.int/whosis/mort/profiles/mort -afro-ken-kenya.pdf
4. European Collaborative Study. Children born to women with HIV -1 infection: natural history and risk of transmission. Lancet. 1991; 337: 253-260.
5. The European Collaborative Study. Natural history of vertically acquired HIV-l infection. Paediatrics. 1994; 94: 815-819.
6. Italian register for HIV infection in children. Features of children perinatally infected with HIV -1 surviving longer than 5 years. Lancet. 1994; 343: 191-195.
7. Vetter, K.M., Djomand, G., Zadi, F., et al. Clinical spectrum HIV disease in a west African city. Project RETRO-CI. Pediatr. Infect. Dis. J. 1996;15: 438-442.
8. Bobat, R., Moddley, D., Coutsoudis, A., et al. The early natural history of vertically transmitted HIV -1 infection in African children from Durban, South Africa. Ann. Trop. Paediatr. 1998; 18: 187-196.
9. Chintu, C., Luo, C., Bhat, G., et al. Impact of the HIV-l on common paediatric illnesses in Zambia. J. Trop. Pediatr. 2000;137: 78-84.
10. Kimani, F., Director of Medical Services, MOH Kenya. Health: Lack of ARV's a risk to 10,000 Children. Daily Nation Newspaper Friday 19th 2008, pg 6.www.nation.co.ke
11. Humblet, P., Calmy, A., Pinoges, L., et al. Offering HAART to children in resource poor settings: The experience of Medicins Sans frontiers. Abstract in XV International AIDS conf. Vol 1, pg 337.
12. Nyandiko, W.M., Ayaya, S.O., Nabakwe, E., et al. Outcomes of HI V-infected children on anti-retroviral therapy at AM PATH HIV clinics in Western Kenya. J. AIDS. 2006; 43: 418-425.
13. Einterz, R.M., Kimaiyo, S., Mengech, H.N.K. et al. Responding to the HIV pandemic: the power of an academic medical partnership. Academic Med. 2007; 82: 812-818.
14. Hesseling, A. C., Schaaf, H.S., Gie, R.P., Starke, J.R. and Beyers, N. A critical review of diagnostic approaches used in diagnosis of childhood tuberculosis. Inter. J. Tuberc. Lung. Dis. 2002; 21: 1038-1045.
15. Mukadi, Y.D., Wiktor, S.Z., Coulibaly, I.M., et al. Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Cote d'Ivoire. AIDS. 1997; 11:1151-1158.
16. Eley, B., Nutall, J., Davis, M. and Smith, L. Initial experience of a public sector antiretrovira1 treatment program for HIV infected children and their infected parents. S. Afr. Med. J. 2004; 94: 643-646.
17. Chintu, C., Bhat, G. J., Walker, A.S. et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004; 364: 1865-1871.
18. Thior, I., Lockman, S., Smeaton, L. M. and Shapiro, L. R. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV Transmission in Botswana:A randomized trial: The Mashi Study. JAMA. 2006; 296: 794.
19. Palombia, L., Marazzib, M. C. and Voetbergc, A. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS. 2007; 21 (suppI 4): 65-71.
20. Nabukeera-Barungi, N., Kalyesubula, I., Kekitiinwa, A., et al. Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala. Ann. Trop. Paediatr. 2007; 27: 123-131.
21. Bolton-Moore, C., Mwangelwa, M., Cantrell, R., et al. Clinical outcomes and CD4 response in children receiving ART at primary Health care facilities in Zambia. JAMA. 2007;298/16: 1888-1899.
22. Kamali, A., Seeley, J.A., Nunn, A.J., et al. The orphan problem: experience of a sub-Saharan African rural population in the AIDS epidemic. AIDS care. 1996; 8:509-515.